
AI's First Blockbuster: Insilico Medicine's Rentosertib Advances to Final Clinical Trials
Insilico Medicine's Rentosertib is poised to become the first drug entirely discovered and designed by artificial intelligence to reach Phase 3 clinical trials—a watershed moment for AI-driven drug discovery that could reshape how the pharmaceutical industry develops treatments.










